The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels
Erika Iivanainen, Susanna Lauttia, Na Zhang, Denis Tvorogov, Jarmo Kulmala, Reidar Grenman, Petri Salven, Klaus EleniusVolume:
78
Year:
2009
Language:
english
DOI:
10.1016/j.mvr.2009.06.010
File:
PDF, 1.08 MB
english, 2009